|
1
|
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.
|
Proc Natl Acad Sci U S A
|
2009
|
5.36
|
|
2
|
Measuring agreement in medical informatics reliability studies.
|
J Biomed Inform
|
2002
|
5.00
|
|
3
|
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.
|
N Engl J Med
|
2012
|
3.15
|
|
4
|
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.
|
Arthritis Care Res (Hoboken)
|
2010
|
2.94
|
|
5
|
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.
|
Ann Intern Med
|
2010
|
2.94
|
|
6
|
Multiple imputation for model checking: completed-data plots with missing and latent data.
|
Biometrics
|
2005
|
2.44
|
|
7
|
Hyperuricemia and risk of stroke: a systematic review and meta-analysis.
|
Arthritis Rheum
|
2009
|
2.07
|
|
8
|
An index of local sensitivity to nonignorable drop-out in longitudinal modelling.
|
Stat Med
|
2005
|
2.00
|
|
9
|
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study.
|
J Clin Oncol
|
2002
|
1.93
|
|
10
|
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.
|
Ann Intern Med
|
2002
|
1.89
|
|
11
|
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis.
|
J Clin Oncol
|
2002
|
1.68
|
|
12
|
A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
|
Leuk Lymphoma
|
2006
|
1.67
|
|
13
|
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma.
|
Cancer Biol Ther
|
2008
|
1.58
|
|
14
|
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.
|
Ann Intern Med
|
2006
|
1.57
|
|
15
|
A simple local sensitivity analysis tool for nonignorable coarsening: application to dependent censoring.
|
Biometrics
|
2006
|
1.50
|
|
16
|
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
|
Clin Cancer Res
|
2007
|
1.47
|
|
17
|
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.
|
J Clin Oncol
|
2002
|
1.44
|
|
18
|
Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours.
|
Cancer Biol Ther
|
2010
|
1.40
|
|
19
|
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies.
|
Cancer Biol Ther
|
2009
|
1.40
|
|
20
|
Reproducibility of the nicotine metabolite ratio in cigarette smokers.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.34
|
|
21
|
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.
|
Clin Cancer Res
|
2008
|
1.32
|
|
22
|
Modeling heaping in self-reported cigarette counts.
|
Stat Med
|
2008
|
1.29
|
|
23
|
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.
|
Neuropsychopharmacology
|
2010
|
1.17
|
|
24
|
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.
|
Mol Ther
|
2010
|
1.15
|
|
25
|
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials.
|
Clin Trials
|
2012
|
1.10
|
|
26
|
DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis.
|
Cancer
|
2004
|
1.10
|
|
27
|
Design and analysis of controlled trials in naturally clustered environments: implications for medical informatics.
|
J Am Med Inform Assoc
|
2002
|
1.07
|
|
28
|
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.
|
Am J Respir Crit Care Med
|
2011
|
1.07
|
|
29
|
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.
|
Breast Cancer Res Treat
|
2010
|
1.07
|
|
30
|
Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study.
|
Stat Med
|
2007
|
1.02
|
|
31
|
Nonignorable censoring in randomized clinical trials.
|
Clin Trials
|
2005
|
0.99
|
|
32
|
Modeling smoking cessation data with alternating states and a cure fraction using frailty models.
|
Stat Med
|
2010
|
0.99
|
|
33
|
Comparison between the analgesic efficacy of transversus abdominis plane (TAP) block and placebo in open retropubic radical prostatectomy: a prospective, randomized, double-blinded study.
|
J Clin Anesth
|
2013
|
0.99
|
|
34
|
A placebo-controlled trial of modafinil for nicotine dependence.
|
Drug Alcohol Depend
|
2008
|
0.98
|
|
35
|
Missing data in model-based pharmacometric applications: points to consider.
|
J Clin Pharmacol
|
2010
|
0.96
|
|
36
|
(31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan.
|
NMR Biomed
|
2012
|
0.95
|
|
37
|
Dietary flaxseed administered post thoracic radiation treatment improves survival and mitigates radiation-induced pneumonopathy in mice.
|
BMC Cancer
|
2011
|
0.94
|
|
38
|
Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.
|
NMR Biomed
|
2014
|
0.94
|
|
39
|
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients.
|
Oncoimmunology
|
2013
|
0.91
|
|
40
|
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.
|
Biol Blood Marrow Transplant
|
2011
|
0.90
|
|
41
|
DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma.
|
Clin Cancer Res
|
2005
|
0.90
|
|
42
|
Sensitivity analysis of causal inference in a clinical trial subject to crossover.
|
Clin Trials
|
2004
|
0.89
|
|
43
|
A method comparison study of timeline followback and ecological momentary assessment of daily cigarette consumption.
|
Nicotine Tob Res
|
2009
|
0.88
|
|
44
|
Nonparametric prediction of event times in randomized clinical trials.
|
Clin Trials
|
2004
|
0.87
|
|
45
|
Occult breast tumor reservoir: biological properties and clinical significance.
|
Horm Cancer
|
2013
|
0.87
|
|
46
|
Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma.
|
Ann Surg Oncol
|
2004
|
0.85
|
|
47
|
Prediction of individual long-term outcomes in smoking cessation trials using frailty models.
|
Biometrics
|
2011
|
0.84
|
|
48
|
Incomplete data: what you don't know might hurt you.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.84
|
|
49
|
Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.83
|
|
50
|
Impact of nonignorable coarsening on Bayesian inference.
|
Biostatistics
|
2007
|
0.83
|
|
51
|
The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas.
|
Ann Surg
|
2015
|
0.83
|
|
52
|
MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib.
|
AJR Am J Roentgenol
|
2013
|
0.82
|
|
53
|
Predicting event times in clinical trials when treatment arm is masked.
|
J Biopharm Stat
|
2006
|
0.81
|
|
54
|
Weibull prediction of event times in clinical trials.
|
Pharm Stat
|
2008
|
0.81
|
|
55
|
Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer.
|
Cancer Chemother Pharmacol
|
2013
|
0.80
|
|
56
|
Effects of menopausal hormonal therapy on occult breast tumors.
|
J Steroid Biochem Mol Biol
|
2013
|
0.79
|
|
57
|
Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.
|
NMR Biomed
|
2015
|
0.79
|
|
58
|
Assessing the fit of parametric cure models.
|
Biostatistics
|
2012
|
0.79
|
|
59
|
Statistical analysis of daily smoking status in smoking cessation clinical trials.
|
Addiction
|
2011
|
0.79
|
|
60
|
Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions.
|
Ann Am Thorac Soc
|
2013
|
0.79
|
|
61
|
Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer.
|
Ann Surg Oncol
|
2005
|
0.78
|
|
62
|
Prediction of event times in the REMATCH Trial.
|
Clin Trials
|
2013
|
0.77
|
|
63
|
Predicting event times in clinical trials when randomization is masked and blocked.
|
Clin Trials
|
2007
|
0.77
|
|
64
|
Multiplicity-calibrated Bayesian hypothesis tests.
|
Biostatistics
|
2010
|
0.76
|
|
65
|
Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial.
|
Stat Med
|
2012
|
0.75
|
|
66
|
A pattern-mixture model for the analysis of censored quality-of-life data.
|
Stat Med
|
2006
|
0.75
|
|
67
|
Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?
|
BJU Int
|
2008
|
0.75
|